Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Premenopausal Breast Cancer × Breast × Clear all

Phase

Status

Completed 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1020 Triple Negative Breast Neoplasms 126 Neoplasm Metastasis 88 Carcinoma, Non-Small-Cell Lung 75 Ovarian Neoplasms 71 Neoplasms 66 Lung Neoplasms 58 Colorectal Neoplasms 53 Melanoma 50 Breast Neoplasms, Male 40 Prostatic Neoplasms 38 Pancreatic Neoplasms 38 Stomach Neoplasms 36 Carcinoma, Renal Cell 32 Sarcoma 28 Squamous Cell Carcinoma of Head and Neck 27 Head and Neck Neoplasms 24 Brain Neoplasms 24 Colonic Neoplasms 23 Endometrial Neoplasms 22 Esophageal Neoplasms 19 Carcinoma, Ovarian Epithelial 19 Urinary Bladder Neoplasms 18 Lymphoma, Non-Hodgkin 18 Carcinoma, Intraductal, Noninfiltrating 18 Recurrence 17 Lymphoma 16 Inflammatory Breast Neoplasms 16 Multiple Myeloma 15 Hodgkin Disease 15

Interventions

pembrolizumab 1 exemestane 1 Leuprolide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02990845 2023-02-22

PEER

National Taiwan University Hospital

Phase 1/2 Terminated

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡